[News Space=Reporter seungwon lee] The '2025 Osaka Kansai World Expo' Korea Pavilion pop-up store, operated by KORAIL Distribution (CEO Park Jeong-hyeon), will officially open on April 13. The '2025 Osaka Kansai World Expo' (hereinafter referred to as Osaka Expo) will be held for six months from April 13 to October 13 on the artificial island of Yumeshima in Osaka, and is one of the world's three largest international events with 158 countries participating. This pop-up store focuses on supporting the global expansion of domestic small and medium-sized enterprises and promoting Korean cultural
[News Space=Reporter seungwon lee] Hyundai Elevator won the 'Winner' award in the product category at Germany's 'Red Dot Design Award 2025'. The product that won Hyundai Elevator the grand prize is the 'Smart Hall Button'. This product combines a foot sensor and AI voice recognition function, allowing you to enter your destination floor without touching it. When a person moves their foot near the 'Smart Hall Button', the AI voice function is activated. The fact that this cutting-edge technology has been incorporated into an intuitive design is considered the background for this award. Hyunda
[News Space=Reporter seungwon lee] Ceragem (CEO Lee Kyung-soo) announced on the 10th that its consolidated sales for 2024 were 546 billion won and operating profit was 2.2 billion won. Ceragem has maintained its position as the No. 1 in the domestic home healthcare appliance industry for the past four years since 2021. Ceragem's domestic sales recovered last year, while overseas sales increased even more. Ceragem explained that the main reason for this was the strengthening of investment in products and services related to the 7care solution in order to transform into a total home healthcare c
[News Space=Reporter seungwon lee] Celltrion announced on the 10th that it recently received approval for the eye disease treatment 'Idenselt (ingredient: aflibercept)' and the bone disease treatment 'Stoboclo-Osenvelt (ingredient: denosumab)' from the Australian Therapeutic Goods Administration (TGA). It has received approval for a total of three biosimilars in the past two weeks. Idenselt has been approved for the indication of myopic choroidal neovascularization (myopic CNV). The approved formulations are injectable (vial) and prefilled syringe (PFS). Celltrion expects that Idengelt will be
[News Space=Reporter seungwon lee] Amorepacific's authentic derma brand AESTURA was selected as the 'No. 1 derma cosmetic facial care brand in sales in Korea' according to the results of the global data analysis company Euromonitor International (Beauty & Personal Care 2025 Edition, based on 2024 retail sales). Estura is growing into a representative K-beauty derma brand in Korea based on the derma heritage that started from Pacific Pharmaceuticals and the research expertise of Amorepacific. Atobarrier Cream, which was launched in 2008 as a hospital-only dermatology cosmetic and was recogn
[News Space=Reporter seungwon lee] Dong-A Pharmaceutical (CEO Baek Sang-hwan) announced on the 10th that its cold medicine brand Panpyrin was ranked first in the cold medicine category of the '2025 Korea Brand Power Index (K-BPI)' hosted by the Korea Productivity Association Consulting (KMAC) for the second consecutive year. The Korea Brand Power Index (K-BPI) is a system in which the Korea Productivity Association Consulting selects and certifies brands that represent Korean consumer life through consumer surveys and evaluations every year. This year, a survey was conducted on a total of 235
[News Space=Reporter seungwon lee] 14 companies listed on the Korea Exchange and 43 companies listed on KOSDAQ are facing the risk of delisting. The Korea Exchange has released the 'Current status of market measures related to the settlement of accounts for corporations with fiscal year ending in December 2024' for listed companies on the Korea Exchange and KOSDAQ. As a result of this settlement, the stock market took market measures, including ▲14 companies experiencing reasons for delisting, ▲4 companies newly designated as management stocks, and ▲3 companies having their designation lifted.
[News Space=Reporter seungwon lee] Singer G-Dragon's music is going into space. This is through a project in collaboration with the Korea Advanced Institute of Science and Technology (KAIST), where G-Dragon is a visiting professor. Galaxy Corporation, G-Dragon's agency, announced that G-Dragon will be carrying out the 'G-Dragon Space Sound Source Transmission Project' at the KAIST Space Research Institute, where he will be transmitting his music and music videos into space. G-Dragon's music video to be sent into space on this day was produced using 'Sora', a video generation AI model by OpenAI
[News Space=Reporter seungwon lee] On April 9, Korea Water Resources Corporation (K-water) signed an agreement with Euro Invest Holding LLC, the developer of the new city development project in Khrodok, Ukraine, in Gumi, Gyeongsangbuk-do, with the main contents being smart city development. This agreement is a follow-up measure to the MOU signed with the Horodosi local government in January of last year to specify the new city development project plan and participation method. Horodox is a logistics hub located in the Lviv Oblast in western Ukraine, and a new city development of 57.7㎢ is plann
[News Space=Reporter seungwon lee] Estige24 (CEO Kim Il-soo), which operates the beauty and healthcare brand Cellreturn, is experiencing a serious liquidity crisis amid rapidly declining sales and widening deficits. It is pointed out that rapid restructuring and risk management are essential to maintain the possibility of survival as a going concern. Currently, Estige24's major shareholders are CEO Kim Il-soo with 86.64%, CEO Kim's spouse Kim Na-yeon with 10.00%, Kim Sol-hyun with 0.01%, and Celltrion Holdings with 3.35%. According to the audit report of the Financial Supervisory Service's ele